These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 352666)

  • 21. Gout.
    JAMA; 1973 Apr; 224(5 Suppl):757-66. PubMed ID: 4349285
    [No Abstract]   [Full Text] [Related]  

  • 22. The management of gout.
    McCarty DJ
    Hosp Pract; 1979 Sep; 14(9):75-8, 83-5. PubMed ID: 478531
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical management of gout.
    Gutman AB
    Postgrad Med; 1972 May; 51(6):61-6. PubMed ID: 5028822
    [No Abstract]   [Full Text] [Related]  

  • 24. Drugs in the treatment of hyperuricemia.
    Elion GB
    Adv Nephrol Necker Hosp; 1974; 3():51-7. PubMed ID: 4219708
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs for gout.
    Med Lett Drugs Ther; 1976 Jun; 18(12):49-51. PubMed ID: 934016
    [No Abstract]   [Full Text] [Related]  

  • 26. Gout.
    Br Med J; 1974 Mar; 1(5905):446-8. PubMed ID: 4816858
    [No Abstract]   [Full Text] [Related]  

  • 27. The management of gout.
    Emmerson BT
    Med J Aust; 1972 Mar; 1(10):475-8. PubMed ID: 5024419
    [No Abstract]   [Full Text] [Related]  

  • 28. Therapy of gout.
    Gaines LM
    Johns Hopkins Med J; 1967 Nov; 121(5):361-4. PubMed ID: 6075623
    [No Abstract]   [Full Text] [Related]  

  • 29. Management of chronic and recurrent gout.
    Ball GV; Freeman D
    Mod Treat; 1971 Nov; 8(4):829-39. PubMed ID: 4334184
    [No Abstract]   [Full Text] [Related]  

  • 30. [Gout (pathogenesis and therapy)].
    Chirone E
    Policlinico Prat; 1968 Feb; 75(6):177-87. PubMed ID: 5744779
    [No Abstract]   [Full Text] [Related]  

  • 31. An approach to hyperuricemia and gout.
    Palella TD; Kelley WN
    Geriatrics; 1984 Nov; 39(11):89-92, 95-6, 101-2. PubMed ID: 6489762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gout and uric acid metabolism.
    Arthritis Rheum; 1970; 13(5):553-69. PubMed ID: 4922854
    [No Abstract]   [Full Text] [Related]  

  • 33. Prophylactic colchicine therapy of intercritical gout. A placebo-controlled study of probenecid-treated patients.
    Paulus HE; Schlosstein LH; Godfrey RG; Klinenberg JR; Bluestone R
    Arthritis Rheum; 1974; 17(5):609-14. PubMed ID: 4606955
    [No Abstract]   [Full Text] [Related]  

  • 34. Pyrazolidines in the treatment of gout.
    Kuzell WC
    Can Med Assoc J; 1968 Nov; 99(21):1038-43. PubMed ID: 5721943
    [No Abstract]   [Full Text] [Related]  

  • 35. Therapeutics of hyperuricaemia and gout.
    Emmerson BT
    Med J Aust; 1984 Jul; 141(1):31-6. PubMed ID: 6738408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physiologic and biochemical basis for the treatment of gout and hyperuricemia.
    Mikkelsen WM; Robinson WD
    Med Clin North Am; 1969 Nov; 53(6):1331-47. PubMed ID: 4900718
    [No Abstract]   [Full Text] [Related]  

  • 37. [Gout: diagnosis and therapy].
    Schlapbach P
    Ther Umsch; 1985 Oct; 42(10):687-90. PubMed ID: 3909489
    [No Abstract]   [Full Text] [Related]  

  • 38. [The internal therapy of patients with uric acid containing urinary calculi].
    Zöllner N
    Urologe; 1968; 7(1):46-50. PubMed ID: 5667553
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical aspects of chronic gout].
    Otto W; Binder E
    Z Gesamte Inn Med; 1966 Sep; 21(18):562-7. PubMed ID: 5990726
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of allopurinol and probenecid.
    Scott JT
    Ann Rheum Dis; 1966 Nov; 25(6 Suppl):623-6. PubMed ID: 5335059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.